Impact of rhG-CSF on Clinical Efficacy and Immune Cell Subsets after Initial Induction Chemotherapy in AML.

Mei Zhou,Qing Zhang, Xi Y Ren, Fu R An,Zhi T Wang,Hui P Wang,Lin L Liu, Zhi M Zhai,Yi Dong, Qian S Tao

Clinical laboratory（2023）

引用 0|浏览12

暂无评分

摘要

Administration of rhG-CSF after initial induction therapy of AML does not affect the clinical remission and relapse rate, but reduces the duration of agranulocytosis and increases the proportion of M-MDSCs and Tregs.

查看译文

关键词

acute myeloid leukemia,recombinant human granulocyte colony-stimulating factor,complete remission,monocytic myeloid-derived suppressor cells,regulatory T cells

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要